Ronald S. Lauder - 10 Feb 2022 Form 4 Insider Report for ESTEE LAUDER COMPANIES INC (EL)

Role
Chairman, Clinique Labs, LLC, Director, 10%+ Owner
Signature
Ronald S. Lauder, by Maureen Sladek, Attorney-in-fact
Issuer symbol
EL
Transactions as of
10 Feb 2022
Net transactions value
-$214,956,000
Form type
4
Filing time
11 Feb 2022, 14:35:52 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EL Class A Common Stock Conversion of derivative security $0 +700,000 $0.000000 700,000 10 Feb 2022 Direct F1, F2
transaction EL Class A Common Stock Sale $214,956,000 -700,000 -100% $307.08 0 10 Feb 2022 Direct
holding EL Class A Common Stock 6,364 10 Feb 2022 by Descendants of RSL 1966 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EL Class B Common Stock Conversion of derivative security -700,000 -13% 4,768,846 10 Feb 2022 Class A Common Stock 700,000 Direct F1, F2, F4
holding EL Class B Common Stock 6,364 10 Feb 2022 Class A Common Stock 6,364 by Descendants of RSL 1966 Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
F2 There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
F3 The Reporting Person disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.
F4 Not applicable.